Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells

…, P Licona-Limon, ET Schmid, F Pelorosso… - Science, 2017 - science.org
Tissue repair is a subset of a broad repertoire of interleukin-4 (IL-4)– and IL-13–dependent
host responses during helminth infection. Here we show that IL-4 or IL-13 alone was not …

[HTML][HTML] Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

M Duarte, F Pelorosso, LN Nicolosi, MV Salgado… - …, 2021 - thelancet.com
Background Angiotensin receptor blockers (ARBs), such as telmisartan, have been
postulated to treat Covid-19-induced lung inflammation. Methods This is a parallel-group, …

Genetic architecture of mouse skin inflammation and tumour susceptibility

DA Quigley, MD To, J Pérez-Losada, FG Pelorosso… - Nature, 2009 - nature.com
Germline polymorphisms in model organisms and humans influence susceptibility to
complex trait diseases such as inflammation and cancer 1 , 2 , 3 , 4 . Mice of the Mus spretus …

Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID‐19

…, HM Vetulli, M Duarte, FG Pelorosso - Drug development …, 2020 - Wiley Online Library
In late 2019, a new coronavirus emerged in Wuhan Province, China, causing lung complications
similar to those produced by the SARS coronavirus in the 2002–2003 epidemic. This …

Renin‐angiotensin system inhibitors in patients with COVID‐19: a meta‐analysis of randomized controlled trials led by the international society of hypertension

…, TA Murray, F Pelorosso… - Journal of the …, 2022 - Am Heart Assoc
Background Published randomized controlled trials are underpowered for binary clinical
end points to assess the safety and efficacy of renin‐angiotensin system inhibitors (RASi) in …

[HTML][HTML] Angiotensin receptor blockers for COVID-19: pathophysiological and pharmacological considerations about ongoing and future prospective clinical trials

RP Rothlin, M Duarte, FG Pelorosso… - Frontiers in …, 2021 - frontiersin.org
COVID-19 pandemic demands a swift response to find therapeutic tools that effectively
reduce morbidity and mortality. Despite initial fears, evidence from retrospective observational …

Identification of Hipk2 as an essential regulator of white fat development

J Sjölund, FG Pelorosso, DA Quigley… - Proceedings of the …, 2014 - National Acad Sciences
Homeodomain-interacting protein kinase 2 (Hipk2) has previously been implicated in the
control of several transcription factors involved in embryonic development, apoptosis, cell …

[HTML][HTML] Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in …

RP Rothlin, FG Pelorosso, M Duarte… - Pharmacology …, 2023 - ncbi.nlm.nih.gov
At the beginning of the COVID-19 pandemic, Gurwitz, 1 taking into account that SARS-CoV-2
virus enters cells after binding to ACE2 (Angiotensin Converting Enzyme 2), proposed the …

Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial. Preliminary report

M Duarte, F Pelorosso, L Nicolosi, MV Salgado… - MedRxiv, 2020 - medrxiv.org
Background Covid-19, the disease caused by SARS-CoV-2, is associated with significant
respiratory-related morbidity and mortality. Angiotensin receptor blockers (ARBs) have been …

[PDF][PDF] Gene expression architecture of mouse dorsal and tail skin reveals functional differences in inflammation and cancer

…, P Huang, KD Halliwill, J Sjölund, F Pelorosso… - Cell reports, 2016 - cell.com
Inherited germline polymorphisms can cause gene expression levels in normal tissues to
differ substantially between individuals. We present an analysis of the genetic architecture of …